EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A comprehensive technology strategy for microbial identification and contamination investigation in the sterile drug manufacturing facility—a case study

Minghui Song, Qiongqiong Li, Chengzhi Liu, Peien Wang, Feng Qin, Lichun Zhang, Yiling Fan, Hong Shao, Guiliang Chen, Meicheng Yang

Frontiers in Microbiology · 12.02.2024 · 15

DOI: 10.3389/fmicb.2024.1327175 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 12.02.2024. Verfasst von Minghui Song und 9 weiteren Autor:innen. Beteiligte Einrichtung: NMPA Key Laboratory for Testing Technology of Pharmaceutical Microbiology, Shanghai Institute for Food and Drug Control, Shanghai, China. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

A comprehensive strategy for microbial identification and contamination investigation during sterile drug manufacturing was innovatively established in this study, mainly based on MALDI-TOF MS for the identification and complemented by sequencing technology on strain typing.

Methods

It was implemented to monitor the bacterial contamination of a sterile drug manufacturing facility, including its bacterial distribution features and patterns. In three months, two hundred ninety-two samples were collected covering multiple critical components of raw materials, personnel, environment, and production water.

Results

Based on our strategy, the bacterial profile across the production process was determined: 241/292 bacterial identities were obtained, and Staphylococcus spp. (40.25%), Micrococcus spp.(11.20%), Bacillus spp. (8.30%), Actinobacteria (5.81%), and Paenibacillus spp. (4.56%) are shown to be the most dominant microbial contaminants. With 75.8% species-level and 95.4% genus-level identification capability, MALDI-TOF MS was promising to be a first-line tool for environmental monitoring routine. Furthermore, to determine the source of the most frequently occurring Staphylococcus cohnii , which evidenced a widespread presence in the entire process, a more discriminating S. cohnii whole-genome SNP typing method was developed to track the transmission routes. Phylogenetic analysis based on SNP results indicated critical environment contamination is highly relevant to personnel flow in this case. The strain typing results provide robust and accurate information for the following risk assessment step and support effective preventive and corrective measures.

Conclusion

In general, the strategy presented in this research will facilitate the development of improved production and environmental control processes for the pharmaceutical industry, and give insights about how to provide more sound and reliable evidence for the optimization of its control program.

Schlagwörter

Stichwörter der Autor:innen

MALDI-TOF MScontamination investigationmicrobial identificationpharmaceutical processsequencing technology

Autor:innen und Institutionen

  • NMPA Key Laboratory for Testing Technology of Pharmaceutical Microbiology, Shanghai Institute for Food and Drug Control, Shanghai, China.
  • Shanghai Quality Inspection and Testing Center for Innovative Biological Products, Shanghai, China.
  • Hangzhou Digital-Micro Biotech Co., Ltd., Hangzhou, China.
  • Shanghai SPH New Asia Pharmaceutical Co., Ltd., Shanghai, China.
  • China State Institute of Pharmaceutical Industry Co., Ltd., Shanghai, China.
  • Shanghai Center for Drug Evaluation and Inspection, Shanghai, China.

Förderung

  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Song, M., Li, Q., Liu, C., Wang, P., Qin, F., Zhang, L., Fan, Y., Shao, H., Chen, G., & Yang, M. (2024). A comprehensive technology strategy for microbial identification and contamination investigation in the sterile drug manufacturing facility—a case study. Frontiers in Microbiology, 15. https://doi.org/10.3389/fmicb.2024.1327175

Vancouver

Song M, Li Q, Liu C, Wang P, Qin F, Zhang L, et al. A comprehensive technology strategy for microbial identification and contamination investigation in the sterile drug manufacturing facility—a case study. Frontiers in Microbiology. 2024;15. doi:10.3389/fmicb.2024.1327175

BibTeX
@article{Song2024,
  author = {Song, Minghui and Li, Qiongqiong and Liu, Chengzhi and Wang, Peien and Qin, Feng and Zhang, Lichun and Fan, Yiling and Shao, Hong and Chen, Guiliang and Yang, Meicheng},
  title = {A comprehensive technology strategy for microbial identification and contamination investigation in the sterile drug manufacturing facility—a case study},
  journal = {Frontiers in Microbiology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fmicb.2024.1327175}
}
Kostenlos starten →